AstraZeneca Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 434,927 | 0.0281% |
Public Companies | 696,279 | 0.0449% |
Private Companies | 1,638,291 | 0.106% |
State or Government | 2,701,892 | 0.174% |
General Public | 212,408,236 | 13.7% |
Institutions | 1,332,424,262 | 85.9% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
155,090,117 | US$19.5b | -0.28% | 0.92% | |||
134,586,821 | US$16.9b | -0.47% | 0.27% | |||
82,740,491 | US$10.4b | 0.23% | 1.62% | |||
73,565,139 | US$9.3b | 0.37% | 0.14% | |||
51,587,810 | US$6.5b | 0% | 10.55% | |||
32,535,981 | US$4.1b | -1.31% | 0.33% | |||
31,884,526 | US$4.0b | 0% | 0.34% | |||
29,791,106 | US$3.7b | -1.97% | 0.22% | |||
27,800,555 | US$3.5b | -0.36% | 0.12% | |||
26,200,617 | US$3.3b | -0.35% | 0.59% | |||
23,133,694 | US$2.9b | 0.08% | 2.43% | |||
20,990,022 | US$2.6b | -1.45% | 1.9% | |||
19,331,574 | US$2.4b | 0.89% | 0.24% | |||
16,723,823 | US$2.1b | 4.76% | 0.43% | |||
13,603,138 | US$1.7b | -2.45% | 0.71% | |||
13,287,412 | US$1.7b | -2.26% | 0.18% | |||
12,766,418 | US$1.6b | -0.02% | 2.44% | |||
12,146,259 | US$1.5b | 3.43% | 1.97% | |||
11,224,128 | US$1.4b | 0.51% | 0.86% | |||
10,764,229 | US$1.4b | -2.25% | 0.36% | |||
10,468,483 | US$1.3b | 0% | 0.2% | |||
10,453,361 | US$1.3b | 0.43% | 1.01% | |||
10,106,984 | US$1.3b | -0.95% | 0.51% | |||
9,788,118 | US$1.2b | -0.75% | 1.56% | |||
9,117,230 | US$1.1b | 0% | 0.39% |